Cargando…

Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China

PURPOSE: More effective approaches are needed to improve the prognosis of non-small-cell lung cancer (NSCLC) patients. Thus, we used the E-warm model to assess how early integration of interdisciplinary palliative care was related to the quality of life (QoL), psychological functioning, pain managem...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mengting, Yu, Huiqing, Yang, Liejun, Yang, Hong, Cao, Haoyang, Lei, Lei, Ma, Liling, Liu, Shihong, Tian, Ling, Wang, Sixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539600/
https://www.ncbi.nlm.nih.gov/pubmed/37781179
http://dx.doi.org/10.3389/fonc.2023.1184961
_version_ 1785113535733301248
author Chen, Mengting
Yu, Huiqing
Yang, Liejun
Yang, Hong
Cao, Haoyang
Lei, Lei
Ma, Liling
Liu, Shihong
Tian, Ling
Wang, Sixiong
author_facet Chen, Mengting
Yu, Huiqing
Yang, Liejun
Yang, Hong
Cao, Haoyang
Lei, Lei
Ma, Liling
Liu, Shihong
Tian, Ling
Wang, Sixiong
author_sort Chen, Mengting
collection PubMed
description PURPOSE: More effective approaches are needed to improve the prognosis of non-small-cell lung cancer (NSCLC) patients. Thus, we used the E-warm model to assess how early integration of interdisciplinary palliative care was related to the quality of life (QoL), psychological functioning, pain management, and nutrition factors of NSCLC patients. METHODS: This randomized controlled trial enrolled 280 newly diagnosed NSCLC patients, which were randomly divided (1:1) into combined early palliative care (CEPC) and standard oncological care (SC) groups. At baseline and after 24 weeks, the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale, Hospital Anxiety and Depression Scale (HADS), and the Patient Health Questionnaire-9 (PHQ-9) were used to assess QoL and psychological function, respectively. The Numerical Rating Scale (NRS) and Patient-Generated Subjective Global Assessment (PG-SGA) were used to assess cancer patients’ pain and nutrition levels. The primary outcome was overall survival (OS). Secondary outcomes comprised changes in the QoL, psychological functioning, pain, and nutrition state. The intention-to-treat method was applied for analysis. This study was registered at www.chictr.org.cn (ChiCTR2200062617). RESULTS: Of the 140 patients enrolled in the CEPC and SC groups, 102 and 82 completed the research. The CEPC group presented higher QoL than the SC group (p < 0.05). Additionally, fewer patients presented depressive symptoms in the CEPC group than in the SC group (p < 0.05), as well as better nutritional status (p = 0.007) and pain management (p = 0.003). Compared to the SC group, CEPC patients had significantly longer OS (20.4 vs. 24.6 months, p = 0.042; HR: 0.19; 95% CI: 0.04-0.85, p = 0.029). CONCLUSION: With combined early palliative care, NSCLC patients lived longer, had better QoL, were psychologically stable, were in less pain, and were more nutritionally satisfied.
format Online
Article
Text
id pubmed-10539600
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105396002023-09-30 Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China Chen, Mengting Yu, Huiqing Yang, Liejun Yang, Hong Cao, Haoyang Lei, Lei Ma, Liling Liu, Shihong Tian, Ling Wang, Sixiong Front Oncol Oncology PURPOSE: More effective approaches are needed to improve the prognosis of non-small-cell lung cancer (NSCLC) patients. Thus, we used the E-warm model to assess how early integration of interdisciplinary palliative care was related to the quality of life (QoL), psychological functioning, pain management, and nutrition factors of NSCLC patients. METHODS: This randomized controlled trial enrolled 280 newly diagnosed NSCLC patients, which were randomly divided (1:1) into combined early palliative care (CEPC) and standard oncological care (SC) groups. At baseline and after 24 weeks, the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale, Hospital Anxiety and Depression Scale (HADS), and the Patient Health Questionnaire-9 (PHQ-9) were used to assess QoL and psychological function, respectively. The Numerical Rating Scale (NRS) and Patient-Generated Subjective Global Assessment (PG-SGA) were used to assess cancer patients’ pain and nutrition levels. The primary outcome was overall survival (OS). Secondary outcomes comprised changes in the QoL, psychological functioning, pain, and nutrition state. The intention-to-treat method was applied for analysis. This study was registered at www.chictr.org.cn (ChiCTR2200062617). RESULTS: Of the 140 patients enrolled in the CEPC and SC groups, 102 and 82 completed the research. The CEPC group presented higher QoL than the SC group (p < 0.05). Additionally, fewer patients presented depressive symptoms in the CEPC group than in the SC group (p < 0.05), as well as better nutritional status (p = 0.007) and pain management (p = 0.003). Compared to the SC group, CEPC patients had significantly longer OS (20.4 vs. 24.6 months, p = 0.042; HR: 0.19; 95% CI: 0.04-0.85, p = 0.029). CONCLUSION: With combined early palliative care, NSCLC patients lived longer, had better QoL, were psychologically stable, were in less pain, and were more nutritionally satisfied. Frontiers Media S.A. 2023-09-14 /pmc/articles/PMC10539600/ /pubmed/37781179 http://dx.doi.org/10.3389/fonc.2023.1184961 Text en Copyright © 2023 Chen, Yu, Yang, Yang, Cao, Lei, Ma, Liu, Tian and Wang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Chen, Mengting
Yu, Huiqing
Yang, Liejun
Yang, Hong
Cao, Haoyang
Lei, Lei
Ma, Liling
Liu, Shihong
Tian, Ling
Wang, Sixiong
Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China
title Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China
title_full Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China
title_fullStr Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China
title_full_unstemmed Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China
title_short Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China
title_sort combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in chongqing, china
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539600/
https://www.ncbi.nlm.nih.gov/pubmed/37781179
http://dx.doi.org/10.3389/fonc.2023.1184961
work_keys_str_mv AT chenmengting combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT yuhuiqing combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT yangliejun combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT yanghong combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT caohaoyang combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT leilei combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT maliling combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT liushihong combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT tianling combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina
AT wangsixiong combinedearlypalliativecarefornonsmallcelllungcancerpatientsarandomizedcontrolledtrialinchongqingchina